A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04555096
Recruitment Status :
(Participants are no longer receiving intervention)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Male or female subjects at least 18 years of age.
Ability to understand and the willingness to sign a written informed consent.
Laboratory-confirmed SARS-CoV-2 infection as determined by a positive PCR test documented prior to randomization